Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nanoscale

• Publication date

  2011-03-10

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1039/c0nr00781aPMID 21173998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ordered nanostructured amphiphile self-assembly materials from endogenous nonionic unsaturated monoethanolamide lipids in water.

  2010cited by this paper
• Endogenous nonionic saturated monoethanolamide lipids: solid state, lyotropic liquid crystalline, and solid lipid nanoparticle dispersion behavior.

  2010cited by this paper
• High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles.

  2010cited by this paper
• Observing self-assembled lipid nanoparticles building order and complexity through low-energy transformation processes.

  2009cited by this paper
• Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.

  2009cited by this paper
• Soft ordered mesoporous materials from nonionic isoprenoid-type monoethanolamide amphiphiles self-assembled in water

  2009cited by this paper
• Prodrugs: design and clinical applications

  2008cited by this paper
• Squalenoylation Favorably Modifies the in Vivo Pharmacokinetics and Biodistribution of Gemcitabine in Mice

  2008cited by this paper
• Prodrug Strategies in Anticancer Chemotherapy

  2008cited by this paper
• A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.

  2007cited by this paper
• Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent.

  2006cited by this paper
• Pressure-jump X-ray studies of liquid crystal transitions in lipids

  2006cited by this paper
• Strategies for data collection and calibration with a pinhole-geometry SAXS instrument on a synchrotron beamline.

  2006cited by this paper
• Monoglyceride self-assembly structures as delivery vehicles

  2006cited by this paper
• Capecitabine: effective oral fluoropyrimidine chemotherapy

  2005cited by this paper
• Progress in liquid crystalline dispersions: Cubosomes

  2005cited by this paper
• Submicron Dispersions of Hexosomes Based on Novel Glycerate Surfactants

  2005cited by this paper
• IDENTIFICATION OF THE CYTOSOLIC CARBOXYLESTERASE CATALYZING THE 5′-DEOXY-5-FLUOROCYTIDINE FORMATION FROM CAPECITABINE IN HUMAN LIVER

  2004cited by this paper
• Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

  2003cited by this paper
• Peptide Washout and Permeability from Glyceryl Monooleate Buccal Delivery Systems

  2002cited by this paper
• In vitro peptide release from liquid crystalline buccal delivery systems.

  2000cited by this paper
• Nontransgenic models of breast cancer.

  2000cited by this paper
• COLLOIDAL DISPERSIONS OF ORDERED LIPID-WATER PHASES

  1999cited by this paper
• Carbamate chiral surfactants for capillary electrophoresis

  1999cited by this paper
• Surfactant self-assembly objects as novel drug delivery vehicles

  1999cited by this paper
• [Discovery and development of novel anticancer drug capecitabine].

  1999cited by this paper
• Synthesis of Stereoisomerically Pure Monoether Lipids

  1999cited by this paper
• Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

  1998cited by this paper
• Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.

  1998cited by this paper
• Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines.

  1996cited by this paper
• Effect of matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines

  1996cited by this paper
• Steroid hormone receptors and tumorigenicity of sublines from breast tumor metastatic MDA-MB 231 cell line.

  1990cited by this paper

• Recent developments with pH-responsive lyotropic liquid crystalline lipid nanoparticles for targeted bioactive agent delivery

  2025cites this paper
• Self-Assembled systems for Nose-to-Brain delivery of Temozolamide (TMZ) in brain tumor therapy.

  2025cites this paper
• Combining Leu-enkephalin nanomedicines with enkephalinase inhibitors: a promising painkiller strategy?

  2025cites this paper
• Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications

  2024cites this paper
• Regulating the structural polymorphism and protein corona composition of phytantriol-based lipid nanoparticles using choline ionic liquids.

  2023cites this paper
• Prodrug Based on Ionic Liquids for Dual-Triggered Release of Thiabendazole

  2023cites this paper
• Novel bioactive cationic cubosomes enhance the cytotoxic effect of paclitaxel against a paclitaxel resistant prostate cancer cell-line.

  2023cites this paper
• Self-Assembled Polymers for Gastrointestinal Tract Targeted Delivery through the Oral Route: An Update

  2023cites this paper
• Lyotropic liquid crystalline 2D and 3D mesophases: Advanced materials for multifunctional anticancer nanosystems.

  2023cites this paper
• Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms

  2022cites this paper
• Current State-of-the-Art and New Trends in Self-Assembled Nanocarriers as Drug Delivery Systems

  2022cites this paper
• Tailoring the self-assembly of lipid-based lyotropic liquid crystalline mesophases with biocompatible ionic liquid aqueous solutions

  2022cites this paper
• Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models

  2022cites this paper
• The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery

  2021cites this paper
• Knowledge-Based Design of 5-Fluororacil Prodrug Liposomal Formulation: Molecular Packing and Interaction Revealed by Interfacial Isotherms and X-ray Scattering Techniques.

  2021cites this paper
• Self-assembly of prodrugs into nanoparticles: evolving nucleosidic analogues to the next paradigm shift in the field of anticancer drug delivery

  2021cites this paper
• Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery.

  2021cites this paper
• Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines.

  2020cites this paper
• A Review of the Current State of Nanomedicines for Targeting and Treatment of Cancers: Achievements and Future Challenges

  2020cites this paper
• In Vitro and In Vivo Toxicity and Biodistribution of Paclitaxel-Loaded Cubosomes as a Drug Delivery Nanocarrier: A Case Study Using an A431 Skin Cancer Xenograft Model.

  2020cites this paper
• Biomimetic Gemcitabine-Lipid Prodrug Nanoparticles for Pancreatic Cancer.

  2020cites this paper
• Enzyme immobilization onto the nanomaterials: Application in enzyme stability and prodrug-activated cancer therapy.

  2019cites this paper
• CD59 receptor targeted delivery of miRNA-1284 and Cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancers

  2019cites this paper
• Fusion dynamics of cubosome nanocarriers with model cell membranes

  2019cites this paper
• Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system.

  2019cites this paper
• Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.

  2019cites this paper
• Paclitaxel-Loaded Self-Assembled Lipid Nanoparticles as Targeted Drug Delivery Systems for the Treatment of Aggressive Ovarian Cancer.

  2018cites this paper
• Nonlamellar liquid crystals: a new paradigm for the delivery of small molecules and bio-macromolecules.

  2018cites this paper
• Lipidic prodrug approach for improved oral drug delivery and therapy

  2018cites this paper
• Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape

  2018cites this paper
• Cyclodextrin Nanosponges in Drug Delivery and Nanotherapeutics

  2018cites this paper
• Theranostic Nanoplatform: Triple-Modal Imaging-Guided Synergistic Cancer Therapy Based on Liposome-Conjugated Mesoporous Silica Nanoparticles.

  2018cites this paper
• Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution.

  2017cites this paper
• Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine.

  2017cites this paper
• Lipid-Drug Conjugate for Enhancing Drug Delivery.

  2017cites this paper
• Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer

  2017cites this paper
• Marine Biopolymers for Anticancer Drugs

  2017cites this paper
• Predicting the release profile of small molecules from within the ordered nanostructured lipidic bicontinuous cubic phase using translational diffusion coefficients determined by PFG-NMR.

  2017cites this paper
• Chemotherapy agent‐unsaturated fatty acid prodrugs and prodrug‐nanoplatforms for cancer chemotherapy

  2017cites this paper
• Direct demonstration of lipid phosphorylation in the lipid bilayer of the biomimetic bicontinuous cubic phase using the confined enzyme lipid A phosphoethanolamine transferase.

  2017cites this paper
• Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds

  2017cites this paper
• Advances in oral delivery of anti-cancer prodrugs

  2016cites this paper
• Nanosponge Carriers- An Archetype Swing in Cancer Therapy: A Comprehensive Review.

  2016cites this paper
• Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy.

  2016cites this paper
• Sterically stabilized spongosomes for multidrug delivery of anticancer nanomedicines.

  2015cites this paper
• Oral Bioavailability: Issues and Solutions via Nanoformulations

  2015cites this paper
• Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging.

  2015cites this paper
• Epidermal growth factor receptor-targeted lipid nanoparticles retain self-assembled nanostructures and provide high specificity.

  2015cites this paper
• Lipid prodrug nanocarriers in cancer therapy.

  2015cites this paper
• The role of solvent swelling in the self-assembly of squalene based nanomedicines.

  2015cites this paper
• Biocompatible Mesoporous and Soft Nanoarchitectures

  2015cites this paper
• Gd-DTPA-Dopamine-Bisphytanyl Amphiphile: Synthesis, Characterisation and Relaxation Parameters of the Nanoassemblies and Their Potential as MRI Contrast Agents.

  2015cites this paper
• The application of nanosponges to cancer drug delivery

  2014cites this paper
• Nanostructured liquid-crystalline particles for drug delivery

  2014cites this paper
• Drug Formulations Based on Self-Assembled Liquid Crystalline Nanostructures

  2014cites this paper
• 5-Fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles.

  2014cites this paper
• Nonlamellar lipid aggregates

  2014cites this paper
• Dextran-based doxorubicin nanocarriers with improved tumor penetration.

  2014cites this paper
• Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells

  2014cites this paper
• New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization and in vitro studies.

  2014cites this paper
• Gadolinium-DTPA amphiphile nanoassemblies: agents for magnetic resonance imaging and neutron capture therapy.

  2014cites this paper
• Drug delivery: beyond active tumour targeting.

  2014cites this paper
• Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.

  2013cites this paper
• Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions.

  2013cites this paper
• The Micellar Cubic Fd3m Phase

  2013cites this paper
• Lipases, liposomes and lipid-prodrugs

  2013cites this paper
• Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions.

  2013cites this paper
• Nanomedical research in Australia and New Zealand.

  2013cites this paper
• Nanomedical research in Australia and New

  2013cites this paper
• Chelating DTPA amphiphiles: ion-tunable self-assembly structures and gadolinium complexes.

  2012cites this paper
• Nanoparticles as delivery carriers for anticancer prodrugs

  2012cites this paper
• Characterization of bupivacaine-loaded formulations based on liquid crystalline phases and microemulsions: the effect of lipid composition.

  2012cites this paper
• Protein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism study.

  2012cites this paper
• Enhancement of biological activities of nanostructured hydrophobic drug species.

  2012cites this paper
• CONTENTS ADVICE TO POSTGRADUATE STUDENTS

  2012cites this paper
• Design, Synthesis, and Characterization of Novel Zwitterionic Lipids for Drug and siRNA Delivery Applications

  2012cites this paper
• Cubic mesophase nanoparticles doped with superparamagnetic iron oxide nanoparticles: a new class of MRI contrast agent

  2012cites this paper
• Lyotropic liquid crystal engineering-ordered nanostructured small molecule amphiphile self-assembly materials by design.

  2012cites this paper
• Nonionic diethanolamide amphiphiles with unsaturated C18 hydrocarbon chains: thermotropic and lyotropic liquid crystalline phase behavior.

  2011cites this paper
• Nanostructured self-assembly materials from neat and aqueous solutions of C18 lipid pro-drug analogues of Capecitabine—a chemotherapy agent. Focus on nanoparticulate cubosomes™ of the oleyl analogue

  2011cites this paper
• Chelating oleyl-EDTA amphiphiles: self-assembly, colloidal particles, complexation with paramagnetic metal ions and promise as magnetic resonance imaging contrast agents

  2011cites this paper
• Steric stabilisation of self-assembled cubic lyotropic liquid crystalline nanoparticles: high throughput evaluation of triblock polyethylene oxide-polypropylene oxide-polyethylene oxide copolymers

  2011cites this paper
• Nonionic diethanolamide amphiphiles with isoprenoid-type hydrocarbon chains: thermotropic and lyotropic liquid crystalline phase behaviour.

  2011cites this paper
• Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.

  2011cites this paper
• Lyotropic liquid crystalline self-assembly material behavior and nanoparticulate dispersions of a phytanyl pro-drug analogue of capecitabine-a chemotherapy agent.

  2011cites this paper
• Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug analogue of Capecitabine--a chemotherapy agent.

  2011cites this paper
• Cavalli R;Leone F;Minelli R;Fantozzi R;Dianzani C. New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization

  year unknowncites this paper